PrintClick here to print
Go Back

February 2012
BMS and Gladstone combat Alzheimer’s disease ‘tsunami’
Code: E021221
February 2012
Follow the leaders
Code: E021222
February 2012
Betting on biosimilars
Code: E021223
February 2012
ADC from A to Z
Code: E021224
February 2012
Sigma-Aldrich looks to buy BioReliance Corp. for $350 million in cash
February 2012
Dynavax, AstraZeneca to move TLR-9 into toxicology studies
February 2012
Merck secures license for Exelixis’ PI3K-delta program
February 2012
Researchers prove iPS cells capable of mirroring disease
February 2012
Seeking a rare and precious prize
Code: E021201